Hydroxytyrosol (HT) from olive oil, a potent bioactive molecule with health 33 benefits, has a poor bioavailability, its free form (free HT) being undetectable so far. 34 This fact leads to the controversy whether attained HT concentrations after olive oil 35 polyphenol ingestion are too low to explain the observed biological activities. Due to 36 this, an analytical methodology to determine free HT in plasma is crucial for 37 understanding HT biological activity. Plasma HT instability and low concentrations 38 have been major limitations for its quantification in clinical studies. Here, we describe a 39 method to detect and quantify free HT in human plasma by using liquid 40 chromatography coupled to tandem mass spectrometry. The method encompasses 41 different steps of sample preparation including plasma stabilization, protein 42 precipitation, selective derivatization with benzylamine, and purification by solid-phase 43 extraction. A high sensitivity (LOD, 0.3 ng/mL), specificity and stability of HT is 44 achieved following these procedures. The method was validated and its applicability 45 was demonstrated by analyzing human plasma samples after olive oil intake. A 46 pharmacokinetic comparison was performed measuring free HT plasma concentrations 47 following the intake of 25 mL of ordinary olive oil (nearly undetectable concentrations) 48 versus an extra-virgin olive oil (C max = 4.40 ng/mL). To our knowledge, this is the first 49 time that an analytical procedure for quantifying free HT in plasma after olive oil 50 dietary doses has been reported. The present methodology opens the door to a better 51 understanding of the relationship between HT plasma concentrations and its beneficial 52 health effects. 53 Keywords: Hydroxytyrosol; virgin olive oil; health; benzylamine derivatization; 54 humans; LC-MS/MS. 55 56 4 1. Introduction 57 Virgin olive oil (VOO) is a vegetable oil, obtained directly from olives using 58 only mechanical extraction. Major components of olive oil are triacylglycerols and 59 small quantities of free fatty acids, being the main fatty acid in olive oil oleic acid (up to 60 83%). Minor components, constitute from 1 to 2% of the total oil weight and include 61 more than 230 chemical compounds (aliphatic and triterpenic alcohols, sterols, 62 hydrocarbons, volatile and phenolic compounds) [1]. Tyrosol, hydroxytyrosol (HT), and 63 their secoiridoid derivatives (ligstroside and oleuropein) contribute for between the 60 64 to 80% of the total phenolic compounds content of virgin olive oil, depending on the 65 olive cultivar and the geographical origin. 66 Among olive oil phenolic compounds, HT is the most potent as antioxidant, and 67 its biological activities have stimulated a large research on its potential role in 68 cardiovascular protection [2, 3]. The oxygen radical absorbance capacity (ORAC) of 69 this phenol, an index of antioxidant activity, is twice that observed for oleuropein (the 70 secoiridoid containing in its structure HT) and three and ten times more for than that for 71 epicatechin (green tea polyphenol) and ascorbic acid, respectively. In in vitro and ex 72 vivo models, HT shows antioxidant properties, higher than that of vitamin E, on lipids 73 and DNA oxidation [4], as well as a broad spectra of bioactive effects [5]. In animal 74 models, HT displays similar activities [6-8] and delays atherosclerosis progression [9, 75 10]. 76 The previous biological activities of HT are relevant for the prevention of 77 cardiovascular diseases (CVD) and some of them have been corroborated in humans 78 after olive oil administration with varying concentrations of phenolic compounds [11-79 14]. In November 2011, the European Food Safety Authority (EFSA) released a health 80 5 claim concerning the benefits of the ingestion of 5 mg/day phenolic compounds from 81 olive oil (including HT, tyrosol, and their secoiridoids) for protecting low density 82 lipoprotein (LDL) from oxidation [15].
Identification and quantification analyses were performed using an Agilent 1200 139 series HPLC system (Agilent Technologies, Wilmington, DE) coupled to a triple 140 quadrupole (6410 Triple Quad LC/MS; Agilent) mass spectrometer with an electrospray 141 interface (EI). 142 The liquid chromatographic separation was performed using an Acquity UPLC ® 143 CSH C 18 column (100 mm x 3.0 mm i.d., 1.7 µm particle size) from Waters Corporation 144 (Milford, MA, USA) maintained at 40ºC with a column oven. The composition of 145 mobile phase A was 0.01% (v/v) formic acid in water, and mobile phase B was 146 acetonitrile. Initial conditions of the mobile phase were 40% B. After 2 min, it was 147 linearly increased to 75% B over one min, then increased linearly to 100% B over 3 148 min, maintained at 100% for 4.5 additional min, to finally return to initial conditions in 149 5.5 min The total run time was 16 min at a flow rate of 0.35 mL/min. The injection 150 volume was 5 µL and the selected reaction monitoring (SRM) mode was employed for 151 quantification. The ion source was operated in positive EI mode. Nitrogen was 152 employed as a drying and nebulizing gas, and a capillary voltage of 4 kV was used. The 153 8 pressure of the nebulizer was set at 30 psi. The source temperature was set to 350 ºC, 154 and a gas flow rate of 10 L/min was used. Peak-response ratios of derivatized HT and 155 the corresponding deuterated analog internal standard were used for the calculation of 156 the concentrations. reaction was stopped by the addition of 4 mL of water. Samples were submitted to a 170 solid-phase procedure using Oasis HLB columns. Cartridges were conditioned with 2 171 mL of methanol and equilibrated with 2 mL of water. After loading the reaction 172 mixture, interferences were washed away sequentially with 2 mL of water and 2 mL of 173 a methanol : water mixture (20:80, v:v 
184
The linearity of the calibration curves was evaluated in a concentration range of 185 1.0-11.0 ng/mL. Calibration standards of HT were prepared for each analytical batch The precision was calculated measuring the coefficient of variation (CV) of the 199 estimated concentrations for five replicates of the QC samples that were analyzed in one 200 day (within-run precision) and also with the data obtained during three validation assays 201 10 that took place during three different days (between-run precision). Precision was 202 considered acceptable if the CV was <15% for the QC with the exception of LLOQ, 203 which was acceptable if the CV was within 20% of the nominal value.
204
The accuracy of the method was evaluated using five replicates of the QC The matrix effect was evaluated using HT free plasma spiked at a low (2.0 212 ng/mL) and a high concentration (10 ng/mL). As this method consists in the detection of 213 a derivatized compound and due to the lack of a pure derivatized-HT standard, the 214 matrix effect was evaluated by measuring the precision and accuracy of the method in 215 plasma obtained from six different donors.
216
The limit of detection (LOD) was estimated using the standard deviations (SD) 217 of the obtained concentrations from six replicates of the LLOQ (1 ng/mL) and the slope 218 (s) of the calibration curve, according to the following formula: LOD = 3.3 * (SD/s).
219
Additionally, at the estimated LOD of the surrogated analytes, it was confirmed that the 220 LOD was at least 3 times the signal to noise ratio of a blank plasma sample. The lower 221 limit of quantification (LLOQ) was the lowest concentration calibrator experimentally 222 tested that presented acceptable accuracy (80-120%) and precision (±20%). administration. Blood was collected into 10 mL tubes containing EDTA and they were 255 centrifuged (1,700 g, 10 min, 4ºC). The plasma aliquots were collected into Eppendorfs 256 containing citric acid (2M, 10% (v/v)). They were immediately stored at -20 ºC and 257 analyzed within a week.
258
The maximum plasma concentration (C max ) and the time to reach C max (t max ) 259 were determined from the curves constructed by plotting the plasma concentrations over formed and its corresponding fragments present one deuterium less (Figure 2 B) . In Da higher than the corresponding non-deuterated analogue. Due to these observations, 290 HT-D 4 was selected as the preferred IS. The identification and quantification of HT and 291 HT-D 4 were performed following parameters described in Table 1 . 292 Once the LC-MS/MS parameters were optimized, the absence of hydrolysis of 
Method validation 299
The linearity of the calibration curve was evaluated from three different batches 300 that were prepared on three different days, as described above. Satisfactory Table 2 . 305 The within-and between-run precision presented acceptable values of CV, and 306 the intra-and inter-day accuracy values, measured as relative error, were always below 307 15% ( Table 2) . 308 The calculated LOD for free HT was 0.3 ng/mL, whereas the LLOQ was 1 309 ng/mL.
310
The matrix effect for derivatized-HT and its corresponding IS was evaluated by 311 duplicate in six different plasma batches at a low (2 ng/mL, QC-L) and a high (10 312 15 ng/mL, QC-H) concentration. As shown in Table 3 , the fact of using different matrices 313 did not affect the precision or the accuracy of the method. The precision for QC-L was 314 12.4% and the accuracy was 14.0 %, for the QC-H the precision was 8.8 % and 7.9 % 315 for the accuracy. pharmacokinetic parameters for free HT after extra-virgin olive oil intake were: AUC = 334 5.3 ng·h/mL, C max = 4.4 ng/mL, T max = 0.25 h, K e = 0.25 h -1 and T 1/2 = 2.8 h. In the case 335 of ordinary olive oil, the C max (0.2 ng/mL) was below the LOD (0.3 ng/mL) and, 336 16 consequently, the corresponding pharmacokinetic parameters could not be calculated.
337
The results clearly show that, following the ingestion of an ordinary olive oil the 338 concentrations of free HT are practically undetectable and, as expected, they are in 339 contrast with the higher HT levels achieved after the extra-virgin olive oil intake. 
Discussion

341
In the present work, we report for the first time the development and validation 342 of an analytical method to detect with high sensitivity free HT in human plasma by LC-343 MS/MS after the intake of dietary doses of olive oil.
344
HT is the most potent phenolic antioxidant present in olive oil. It displays 345 several health promoting properties including antioxidant, anti-inflammatory, 346 antiproliferative, antimicrobial, among other cardio and neuroprotective activities [32] .
347
To obtain a better understanding of HT biological activities in humans it is crucial to 348 measure the levels of free HT that reach blood circulation. The extensive metabolism 349 that this compound undergoes after absorption, transforms it into a large variety of (which represents a 0.3% of the administered dose). This low bioavailability is not 393 surprising if we take into account (i) that HT absorption is around 10% [37] and that HT 394 is subject to an extensive metabolism. In previous urine analyses from metabolism 395 studies, we found that free hydroxytyrosol represents 1-10% of total HT metabolites 396 (Pérez-Mañá et al., 2015) . Considering these facts, the expected % of free HT in plasma 397 would range between 0.1 and 1%, which is consistent with our results.
398
According to in vitro studies, HT is one of the most potent antioxidants known 399 [2, 3] . In the light of these results, the concentrations of the free HT that we found in 400 plasma after olive oil intake cannot explain a direct in vivo antioxidant activity of HT.
401
However, besides its direct chemical antioxidant activity it has been suggested that the 402 biological effects of HT could be mediated through other secondary mechanisms such 403 as transcriptomic effects [26] and the activity of metabolites [22, 23] .
404
The present study has both strengths and limitations. The strength of this 405 methodology is the high selectivity and sensitivity achieved after the derivatization 406 procedure of HT and its subsequent LC-MS/MS analysis. A limitation of the present 407 work is the small sample size of the pharmacokinetic study. More robust 408 pharmacokinetic data with a larger sample size will be obtained from future studies. In conclusion, we report here a method that allows for the first time the 410 quantification of free HT in plasma after extra-virgin olive oil intake compatible with its 411 real life dietary consumption. The methodology developed here is suitable to be used 412 for administration studies of olive oil and nutritional supplements. The measurement of 413 free HT in plasma will be a crucial tool for a better understanding of the dose-effect of 414 this potent antioxidant and its beneficial health effects. 
